Steady-State Pharmacokinetics and Dose Proportionality of Troglitazone and Its Metabolites
- 1 September 1999
- journal article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 39 (9) , 920-926
- https://doi.org/10.1177/00912709922008533
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Improvement in the gastrointestinal absorption of troglitazone when taken with, or shortly after, foodBritish Journal of Clinical Pharmacology, 1998
- Lack of Effect of Type II Diabetes on the Pharmacokinetics of Troglitazone in a Multiple-Dose StudyThe Journal of Clinical Pharmacology, 1997
- Meta‐Analysis of Steady‐State Pharmacokinetics of Troglitazone and Its MetabolitesThe Journal of Clinical Pharmacology, 1997
- TroglitazoneDrugs, 1997
- MetforminNew England Journal of Medicine, 1996
- Improvement in Glucose Tolerance and Insulin Resistance in Obese Subjects Treated with TroglitazoneNew England Journal of Medicine, 1994
- Metabolic Effects of New Oral Hypoglycemic Agent CS-045 in NIDDM SubjectsDiabetes Care, 1992
- Effect of New Oral Antidiabetic Agent CS-045 on Glucose Tolerance and Insulin Secretion in Patients with NIDDMDiabetes Care, 1991
- Sulfonylurea Drugs: Mechanism of Antidiabetic Action and Therapeutic UsefulnessDiabetes Care, 1978